Study guide

11.2 Labeling & Packaging of Dispensed Drugs

Illinois MPJE Pharmacy Jurisprudence

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Illinois MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy

2 Chapter 2: Federal Controlled Substances Foundations

2.1 CSA Schedules I–V & Illinois Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss

3 Chapter 3: Federal Drug Regulation, Privacy & Supply Chain

3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity

4 Chapter 4: IDFPR, Licensure & Eligibility

4.1 IDFPR Authority & Sources of Illinois Pharmacy Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & Experiential Requirements

5 Chapter 5: Renewal, CE, PIC & Discipline

5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 Impaired Practitioners & Mandatory Reporting

6 Chapter 6: Technicians, Interns & Supervision

6.1 Technician Registration, Training & Certification 6.2 Supervision, Scope & No Fixed Tech Ratio 6.3 Intern Scope, Delegation & Final Verification

7 Chapter 7: Prescription Authority & Validity

7.1 Who May Prescribe in Illinois 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (720 ILCS 570 + Federal) 7.4 Refills, Partial Fills & E-Prescribing Mandate

8 Chapter 8: Advanced IL Pharmacist Practice

8.1 Collaborative Practice Agreements & Clinical Services 8.2 Immunizations & Vaccine Administration 8.3 Naloxone Access & Opioid Antagonists 8.4 Drug Administration & Therapy Management

9 Chapter 9: Counseling, DUR & Patient Safety

9.1 Patient Counseling Requirements 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs

10 Chapter 10: ILPMP & Opioid Public-Health Laws

10.1 Illinois PMP Overview, Reporting & Access 10.2 Mandatory Queries, Designees & Documentation 10.3 Legitimate Medical Purpose & Red Flags

11 Chapter 11: Dispensing: Transfers, Labels & Substitution

11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine

12 Chapter 12: Pharmacy Operations & Facilities

12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Automated Systems & Self-Service Kiosks 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Delivery & Remote Services

13 Chapter 13: Compounding & Hazardous Drugs

13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Illinois Compounding Rules & Beyond-Use Dates

14 Chapter 14: Test-Day Strategy & Final Review

14.1 When Illinois Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps

11.2 Labeling & Packaging of Dispensed Drugs

Key Takeaways Explain This Topic AI

225 ILCS 85 §22 requires outpatient prescription labels to show pharmacy name/address, dispenser name or initials, fill date, patient name, prescription serial number, prescriber’s last name, directions for use, and drug name(s), dosage, and quantity.

Federal dispensed-label expectations under the FD&C / Durham-Humphrey framework still require patient-specific directions and identifying information; insurance IDs and technician DEA numbers are not label elements.

Poison Prevention Packaging Act (PPPA) child-resistant packaging is the outpatient default for oral legend drugs, with recognized exemptions such as sublingual nitroglycerin and patient/prescriber requests for non-child-resistant containers when documented.

Beyond-use dates on pharmacy labels and prepack labels must not exceed product stability limits; Illinois prepackaging rules (1330.730) cap prepack BUD at the manufacturer date or 12 months, whichever is less.

Institutional unit-dose and medication-order labeling differ from community outpatient vials—high-level institutional labels focus on drug identity, strength, lot/BUD, and patient/order identifiers rather than full retail counseling-style vial copy.

Last updated: August 2026

11.2 Labeling & Packaging of Dispensed Drugs

Quick Answer: Under 225 ILCS 85 §22 , the label on an outpatient dispensed prescription container must show the pharmacy name and address , name or initials of the person authorized to practice pharmacy who sold/dispensed it, fill date , patient name , prescription serial number , prescriber’s last name , directions for use , and the proprietary or established name(s) , dosage , and quantity . Pair that with PPPA child-resistant packaging , appropriate auxiliary labels , and a lawful beyond-use date . Institutional unit-dose labeling is a different model—do not paste retail vial rules onto every hospital dose.

After a transfer or original adjudication succeeds, the physical product must leave the pharmacy in a lawful package with a complete label . Labeling failures are high-visibility IDFPR and civil-liability problems because the patient uses the label every day.

Illinois Outpatient Label Elements (225 ILCS 85 §22)

Section 22 states that when a drug is dispensed pursuant to a prescription of an authorized practitioner, the label on the box, bottle, vessel, or package shall show:

Element Statute focus Exam failure mode

(a) Pharmacy name and address Identifies the dispensing site Missing store identity; wrong pharmacy name after central-fill

(b) Name or initials of the person authorized to practice pharmacy selling/dispensing Accountability for the professional act Blank dispenser field; unregistered person as sole “dispenser” identity

  • (c) Date the prescription was filled Temporal record for counseling/refills Undated vial
  • (d) Patient name Who may use the drug Nickname-only chaos; wrong patient label
  • (e) Serial number as filed in prescription files Retrieval and recall readiness No Rx number on label
  • (f) Last name of the practitioner who prescribed Prescriber identity Missing or wrong prescriber

(g) Directions for use as on the prescription Safe administration “Use as directed” with no usable directions when the order had specifics

(h) Proprietary or established name(s), dosage, and quantity What and how much was dispensed Strength omitted when multiple strengths exist

The statute also notes that drug name/dosage/quantity appear except as otherwise authorized by Department rule —so do not invent permanent exceptions on the exam unless the stem supplies a recognized rule pathway.

Federal floor (still tested)

Federal dispensed-prescription labeling under the FD&C Act / Durham-Humphrey framework expects patient-specific directions for use and identifying information for the dispensed product. The Illinois MPJE bank theme is consistent: patient SSN and technician DEA numbers are not federal label requirements. When federal and Illinois both apply, put all required Illinois elements on the label—satisfying only a thin federal minimum is not enough for Illinois practice.

  • What is not a substitute for label elements
  • Insurance BIN/PCN/group numbers
  • Copay stickers alone
  • Manufacturer stock bottle labeling left visible without a pharmacy label
  • Bag tags that fall off and never reach the container the patient stores at home

If the vial the patient takes home is incomplete, the pharmacy failed—even if the computer screen looked perfect.

Auxiliary Labels and Counseling-Linked Warnings

Auxiliary labels (take with food, may cause drowsiness, shake well, avoid alcohol, finish all medication, external use only) are not a complete list in §22, but they are standard professional practice and often intertwined with counseling duties and manufacturer warnings. High-yield habits:

Match auxiliaries to drug risk (e.g., opioids and benzodiazepines → drowsiness/alcohol; antibiotics suspensions → shake well/refrigerate when required)

  • Do not use auxiliaries as a substitute for verbal counseling when counseling is required
  • Ensure auxiliaries do not obscure required primary label elements

Medication Guides, REMS materials, and PPI/leaflets may be required for specific products under FDA programs—those are additional to the vial label, not replacements for §22 elements.

Child-Resistant Packaging (PPPA)

The federal Poison Prevention Packaging Act (PPPA) generally requires child-resistant (CR) packaging for oral prescription drugs dispensed for household use. Exam classics:

  • Rule Application
  • Default Use CR containers for outpatient oral legend drugs
  • Exempt products Sublingual nitroglycerin is the iconic exemption (emergency access)
  • Patient request Patient may request non-CR packaging
  • Prescriber request Prescriber may request non-CR for a patient
  • Documentation Document non-CR requests; do not silently strip CR for convenience
  • Easy-open for all “We never use CR lids” is not a lawful default

Illinois community practice still operates under this federal packaging floor. A correctly labeled amoxicillin suspension in a non-CR vial without a valid exemption/request is still a packaging violation.

Beyond-Use Dates on Labels

A beyond-use date (BUD) tells the patient the last date the pharmacy stands behind the product as labeled under its storage conditions. Illinois administrative definitions even define “Beyond Use Date” in relation to drug dating for practice rules. Practical dispensing rules of thumb for MPJE teaching (without inventing product-specific chemistry):

Do not assign a BUD beyond the manufacturer’s expiration for the stock used

For reconstituted products, follow manufacturer stability (often days under refrigeration)—print the shorter date, not the stock bottle’s multi-year expiration

For prepackaged drugs under 68 Ill. Adm. Code 1330.730 , prepack labels need name and strength , manufacturer/distributor , BUD , and lot ; maximum prepack BUD is the manufacturer’s date or 12 months, whichever is less

Automated counting devices may keep lot/BUD in traceable, inspectable records instead of every cassette label only when the rule’s alternative-record pathway is met

Trap: Printing a one-year BUD on a reconstituted antibiotic that expires in 10 days after mixing.

Institutional / Unit-Dose Labeling (High Level)

Community outpatient vials and institutional unit-dose systems solve different problems.

Community outpatient vial Institutional unit-dose / med-order packaging

Full §22-style patient counseling label for home use Often smaller unit labels: drug, strength, form, lot, BUD, barcode

Patient takes product home for self-administration Nurse/caregiver administers from cart or automated cabinet

Serial Rx number + full directions on the vial Directions live primarily in the medication administration record (MAR) / order

PPPA CR packaging default for household use Institutional packaging/storage rules; not always “vial to go home”

When a hospital discharges a patient with a facility-provided take-home supply, labeling expectations shift back toward outpatient completeness . Do not assume every institutional strip label is enough for community take-home dispensing.

Multi-med packaging note

Illinois also regulates patient med paks (multi-med dispensing) under 1330.740 : with consent, solid orals may be packaged by dosing time with expanded label content (patient name, serials, each drug’s identity/quantity, directions, storage, prescribers, preparation date, pharmacy identity, and BUD rules). If a vignette describes a med pak, look for consent and per-drug identification , not only a single drug name.

  • Practical Labeling Workflow
  • Select correct product (NDC, strength, form)
  • Assign serial number and capture dispenser identity
  • Generate label with all §22 elements
  • Choose CR packaging unless exemption/request applies
  • Add auxiliaries and required MedGuides/REMS handouts
  • Set BUD from manufacturer data + preparation conditions
  • Final verification against hard copy/eRx before release
  • Counsel when required (Chapter 9)—label text is not a full counseling substitute
  • Exam Scenarios

Scenario A. Label missing prescriber last name and Rx serial number → incomplete under §22 even if drug name and patient name appear.

Scenario B. Patient requests easy-open caps for arthritis → document request; non-CR allowed; still keep complete label.

Scenario C. Sublingual nitroglycerin dispensed in non-CR packaging → generally consistent with PPPA exemption purpose (emergency access).

Scenario D. Unit-dose hospital cart fill labeled with drug/strength/lot/BUD but no full outpatient directions on each blister → ordinary for inpatient unit-dose; different from community take-home vial standards.

  • Common Traps
  • Omitting pharmacy address or Rx serial number
  • Treating insurance fields as legal label content
  • Ignoring PPPA defaults
  • BUD longer than product stability after reconstitution or prepack limits

Applying full community label rules to every institutional unit dose—or the reverse, sending patients home with incomplete institutional stickers

Master §22 elements , PPPA packaging , BUD discipline , and the community vs institutional split. Section 11.3 covers which product may go in that labeled vial when brand and generic both exist.